scispace - formally typeset
V

Violetta Cecchetti

Researcher at University of Perugia

Publications -  151
Citations -  3491

Violetta Cecchetti is an academic researcher from University of Perugia. The author has contributed to research in topics: Benzothiazine & Efflux. The author has an hindex of 32, co-authored 146 publications receiving 3004 citations. Previous affiliations of Violetta Cecchetti include Rega Institute for Medical Research & University of Düsseldorf.

Papers
More filters
Journal ArticleDOI

A 1,8-naphthyridone derivative targets the HIV-1 Tat-mediated transcription and potently inhibits the HIV-1 replication.

TL;DR: The naphthyridone 3 (HM13N), described in the present study, is a promising anti-HIV agent due to its ability to inhibit the HIV-1 Tat-mediated transcription and the potent antiviral activity observed in acutely, chronically, and latently infected cells.
Journal ArticleDOI

Effects of Novel 6-Desfluoroquinolones and Classic Quinolones on Pentylenetetrazole-Induced Seizures in Mice

TL;DR: The relationship between the chemical structure and the proconvulsant activity of 6-desfluoroquinolone derivatives was studied and it was observed that, in terms of toxicity to the central nervous system (CNS), the C-6 substituent also appears to play an important role.
Journal ArticleDOI

6-Aminoquinolones as new potential anti-HIV agents.

TL;DR: Active quinolone derivatives very efficiently interact with TAR RNA, which suggests a nucleic acid-targeted mechanism of action in HIV-1 replication.
Journal ArticleDOI

Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.

TL;DR: These compounds, in combination with ciprofloxacin, were able to completely restore its antibacterial activity against both S. aureus SA-K2378 and SA-1199B, norA-overexpressing strains.
Journal ArticleDOI

Quinolonecarboxylic acids. 2. Synthesis and antibacterial evaluation of 7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzothiazine-6-carboxylic acids.

TL;DR: The compound 9-fluoro-10-(4-methyl-1-piperazinyl)-7-oxo-2,3-dihydro-7H-pyrido (MF-934) has been found to possess, together with the antibacterial activity, a weak acute toxicity and interesting pharmacokinetic characteristics in several animal species.